logo

For the Inventor, By the Inventor

Palau-solita i Plegamans, Spain

Palau Pharma, S.a.


USPTO Granted Patents = 12

% Expired Patents = 66.7



Forward Citations = 119

Loading Chart...
Loading Chart...

25 inventors (with patents filed for the assignee):

goldMedal Carmen Almansa Rosales (7 out of 8 patents)

silverMedal Marina Virgili Bernadó (3 out of 5 patents)

bronzeMedal Javier Bartroli Orpi (3 out of 4 patents)

4.  Alberto Gallardo Ruiz (2 out of 5 patents)

5.  Keith Lorimer (2 out of 13 patents)

6.  Robert Soliva Soliva (2 out of 3 patents)

7.  Concepción González González (2 out of 2 patents)

8.  Antonio Cánovas Paredes (2 out of 2 patents)

9.  Elies Molins Grau (2 out of 2 patents)

10.  Anna Roig Serra (2 out of 2 patents)

11.  Kevin Meyer (2 out of 2 patents)

12.  Jorge Salas Solana (1 out of 2 patents)

13.  Sergio Rodriguez Escrich (1 out of 1 patent)

14.  Maria Cristina Sicre González (1 out of 1 patent)

15.  Elena Carceller González (1 out of 1 patent)


12 patents:

1. 8536194 - Pyrazolopyridine derivates (2013-09-17),
2. 8501735 - N-containing heteroaryl derivatives as JAK3 kinase inhibitors (2013-08-06),
3. 8476456 - Process for the preparation of 4-(imidazol-1-yl)benzenesulfonamide derivatives (2013-07-02),
4. 8431580 - [object Object] (2013-04-30),
5. 8309105 - Triflusal-containing polymers for stent coating (2012-11-13),
6. 8258296 - Crystalline antifungal compounds (2012-09-04),
7. 7879867 - Crystalline antifungal compounds (2011-02-01),
8. 7589125 - 2,4-dihydroxybenzoic acid derivatives (2009-09-15),
9. 7550497 - Phosphoramide derivatives (2009-06-23),
10. 7468376 - Pyrazolopyridine derivates (2008-12-23),
11. 7445789 - Biocompatible polymeric systems carrying triflusal or HTB (2008-11-04),
12. 7351836 - Method of preparing 4-(imidazol-1-yl)benzenesulphonamide derivatives (2008-04-01),
Company Overview
Palau Pharma, S.A. is a biopharmaceutical company based in Palau-solita i Plegamans, Spain, specializing in the development and manufacturing of innovative therapeutic solutions. The company focuses on advanced drug formulations and delivery systems, aiming to address unmet medical needs across various therapeutic areas. With a commitment to research and development, Palau Pharma leverages cutting-edge technologies to enhance patient outcomes and improve the efficacy of treatments in the healthcare landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

12 Patents

#1 in Palau-solita i Plegamans

#176 in Spain

#48,163 in the World

Palau-solita i Plegamans, ES
Palau-solita i Plegamans, Spain

Palau Pharma, S.a.

Forward Citations = 119

25 inventors:

goldMedal Carmen Almansa Rosales (7 out of 8 patents)

silverMedal Marina Virgili Bernadó (3 out of 5 patents)

bronzeMedal Javier Bartroli Orpi (3 out of 4 patents)

4.  Alberto Gallardo Ruiz (2 out of 5 patents)

5.  Keith Lorimer (2 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Palau Pharma, S.a.. Retrieved from https://idiyas.com/company/palau-pharma-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…